Related Experiment Video
Updated: Aug 23, 2026

Development of an In Vitro Ocular Platform to Test Contact Lenses
Published on: April 6, 2016
Ocular discomfort at the initial wearing of rigid gas permeable contact lenses
Hiroki Fujita1, Kenji Sano, Shuji Sasaki
1Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University Graduate School, Tokyo, Japan. hirokicell@yahoo.co.jp
Purpose:
To evaluate the relationship between ocular discomfort in the initial wearing of rigid gas permeable contact lenses (RGPCL) and the time required to adapt to RGPCL as measured by using the visual analogue scale (VAS).
Methods:
RGPCL were prescribed for 89 patients (178 eyes) with myopia or myopic astigmatism and no history of wearing contact lenses. The patients who stopped wearing RGPCL after 1 week because of ocular discomfort were defined as dropouts, and those who adapted to regular full-time RGPCL wear were defined as successful wearers. VAS scores were measured at several intervals for 1 month after the initial wearing of the lenses. The number of days required to adapt to wearing RGPCL was defined as the adaptation time.
Results:
Four patients were dropouts due to ocular discomfort (eight eyes; 4.5%). VAS scores were significantly lower in successful wearers than in dropouts at 1 week, although their VAS scores were not different at 1 day. VAS scores of the successful wearers at 1 week were significantly lower than those at 1 day. The average time required to adapt to RGPCL was 23.0 +/- 22.1 days for the 85 successful wearers. Lower VAS scores at 1 day or 1 week were significantly correlated with a shorter adaptation time in the successful RGPCL wearers.
Conclusions:
Our results indicate that the VAS score might be useful for predicting successful RGPCL use and the adaptation time required by successful wearers.
Related Concept Videos
Focusing of Light in the Eye
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Accessory Structures of the Eye
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Photoreceptors and Visual Pathways